Literature DB >> 28941312

The Dual Role of Treg in Cancer.

M Frydrychowicz1, M Boruczkowski1, A Kolecka-Bednarczyk1, G Dworacki1.   

Abstract

Regulatory T cells (Tregs) represent a small subpopulation of CD4+ cells. Tregs are characterized by the expression of transcription factor Forkhead box protein 3 (FoxP3), also known as scurfin. Tregs are modulators of adaptive immune responses and play an important role in maintaining tolerance to self-antigens, providing the suppression associated with tumour microenvironment as well. These immunomodulatory properties are the main reason for the development of numerous therapeutic strategies, designed to inhibit the activity of cancer cells. However, due to Treg subpopulation diversity and its many functional pathways, the role of these cells in the cancer development and progression is still not fully understood.
© 2017 The Foundation for the Scandinavian Journal of Immunology.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28941312     DOI: 10.1111/sji.12615

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  32 in total

Review 1.  The opposing roles of CD4+ T cells in anti-tumour immunity.

Authors:  Tomasz Ahrends; Jannie Borst
Journal:  Immunology       Date:  2018-04-27       Impact factor: 7.397

2.  Effects of transarterial chemoembolization on regulatory T cell and its subpopulations in patients with hepatocellular carcinoma.

Authors:  Hana Park; Jae Hyung Jung; Min Kyung Jung; Eui-Cheol Shin; Simon Weonsang Ro; Jeon Han Park; Do Young Kim; Jun Yong Park; Kwang-Hyub Han
Journal:  Hepatol Int       Date:  2020-02-18       Impact factor: 6.047

3.  Two novel human anti-CD25 antibodies with antitumor activity inversely related to their affinity and in vitro activity.

Authors:  Deyong Song; Xiu Liu; Chuangchuang Dong; Qiaoping Wang; Chunjie Sha; Chuan Liu; Zhenfei Ning; Jing Han; Hong Liu; Mengqi Zong; Yanyan Zhao; Ying Li; Guangsheng Liu; Xin Shao; Changlin Dou
Journal:  Sci Rep       Date:  2021-11-25       Impact factor: 4.379

Review 4.  Electroporation and Immunotherapy-Unleashing the Abscopal Effect.

Authors:  Tobias Freyberg Justesen; Adile Orhan; Hans Raskov; Christian Nolsoe; Ismail Gögenur
Journal:  Cancers (Basel)       Date:  2022-06-10       Impact factor: 6.575

Review 5.  A Proposed Treatment Approach to Treat Lethal Mutating Cancers.

Authors:  Kevin Roe
Journal:  Pharm Res       Date:  2020-02-13       Impact factor: 4.200

6.  The effects of TNF-α/TNFR2 in regulatory T cells on the microenvironment and progression of gastric cancer.

Authors:  Yang Qu; Xianhao Wang; Shuai Bai; Liling Niu; Gang Zhao; Yuan Yao; Bin Li; Hui Li
Journal:  Int J Cancer       Date:  2021-11-16       Impact factor: 7.316

7.  A five-gene signature is a prognostic biomarker in pan-cancer and related with immunologically associated extracellular matrix.

Authors:  Chunlai Yu; Mingliang You; Peizhen Zhang; Sheng Zhang; Yuzhu Yin; Xiao Zhang
Journal:  Cancer Med       Date:  2021-06-14       Impact factor: 4.452

Review 8.  Inhibition of the CCL5/CCR5 Axis against the Progression of Gastric Cancer.

Authors:  Donatella Aldinucci; Naike Casagrande
Journal:  Int J Mol Sci       Date:  2018-05-16       Impact factor: 5.923

Review 9.  Exploring the links between cancer and placenta development.

Authors:  Vincenzo Costanzo; Alberto Bardelli; Salvatore Siena; Sergio Abrignani
Journal:  Open Biol       Date:  2018-06       Impact factor: 6.411

Review 10.  Roles of the immune system in cancer: from tumor initiation to metastatic progression.

Authors:  Hugo Gonzalez; Catharina Hagerling; Zena Werb
Journal:  Genes Dev       Date:  2018-10-01       Impact factor: 11.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.